Delving into proteoforms with higher throughput
Delving into proteoforms with higher throughput Our patented bottom-up DDA proteomics platform technology, ProQuant® , was used to study apolipoprotein E (apoE), a polymorphic protein with key roles in longevity and Alzheimer’s disease. Our experiments testing...
Non-hypothesis-driven identification of protein glycation in diabetes
Non-hypothesis-driven identification of protein glycation in diabetes We used our patented DDA proteomics methodology to investigate protein and post-translational markers of type II diabetes in a small (30-person) carefully controlled study comparing patients...
ProQuant® is precise, but is it accurate as well?
ProQuant® is precise, but is it accurate as well? Our patented DDA bottom-up proteomics protocol makes several changes to a traditional bottom-up proteomics method, in particular in the way in which the MS and bioinformatics methods combine to quantify...